全文获取类型
收费全文 | 2633篇 |
免费 | 142篇 |
国内免费 | 11篇 |
专业分类
耳鼻咽喉 | 12篇 |
儿科学 | 39篇 |
妇产科学 | 34篇 |
基础医学 | 322篇 |
口腔科学 | 97篇 |
临床医学 | 171篇 |
内科学 | 621篇 |
皮肤病学 | 73篇 |
神经病学 | 399篇 |
特种医学 | 98篇 |
外科学 | 299篇 |
综合类 | 8篇 |
预防医学 | 89篇 |
眼科学 | 22篇 |
药学 | 168篇 |
中国医学 | 5篇 |
肿瘤学 | 329篇 |
出版年
2023年 | 24篇 |
2022年 | 45篇 |
2021年 | 63篇 |
2020年 | 32篇 |
2019年 | 49篇 |
2018年 | 71篇 |
2017年 | 46篇 |
2016年 | 67篇 |
2015年 | 91篇 |
2014年 | 119篇 |
2013年 | 126篇 |
2012年 | 167篇 |
2011年 | 182篇 |
2010年 | 107篇 |
2009年 | 102篇 |
2008年 | 158篇 |
2007年 | 173篇 |
2006年 | 173篇 |
2005年 | 179篇 |
2004年 | 176篇 |
2003年 | 149篇 |
2002年 | 139篇 |
2001年 | 37篇 |
2000年 | 21篇 |
1999年 | 32篇 |
1998年 | 25篇 |
1997年 | 30篇 |
1996年 | 19篇 |
1995年 | 23篇 |
1994年 | 12篇 |
1993年 | 17篇 |
1992年 | 11篇 |
1991年 | 11篇 |
1990年 | 13篇 |
1989年 | 12篇 |
1988年 | 6篇 |
1987年 | 7篇 |
1986年 | 8篇 |
1985年 | 4篇 |
1984年 | 12篇 |
1983年 | 5篇 |
1982年 | 9篇 |
1981年 | 7篇 |
1980年 | 3篇 |
1979年 | 2篇 |
1976年 | 2篇 |
1975年 | 4篇 |
1974年 | 3篇 |
1972年 | 2篇 |
1937年 | 1篇 |
排序方式: 共有2786条查询结果,搜索用时 31 毫秒
41.
42.
Petruzzi M De Benedittis M Cortelazzi R Milillo L Lucchese A Serpico R Grassi FR 《Clinical oral investigations》2012,16(5):1347-1352
Objectives
Implant rehabilitation in oral lichen planus (OLP) is a major challenge for clinicians and patients. There is limited scientific evidence, primarily case reports and small case series. We conducted a literature review of data on the effectiveness and safety of implant rehabilitation in OLP patients.Material and methods
We searched MEDLINE, Embase and Cochrane databases for articles on implant placement in OLP patients (searches from 1980 to 2011).Results
Eight studies (41 OLP patients rehabilitated with 135 implants) met the inclusion criteria. Survival rate of implants was 94.8% over a mean follow-up of 56.5?months.Conclusions
There is very limited evidence on the safety and benefits of implant placement in OLP patients. Implant loss appears not to be directly related to OLP, but linked to factors such as parafunctions, poor bone quality and marginal mandibular resection. The benefits and harms of using implants in people with OLP require thorough evaluation in properly designed randomised, controlled studies.Clinical relevance
OLP is not an absolute contraindication for implant insertion and there is no increased risk of failure. Implants should be positioned only if mucosal signs and symptoms are in the remission phase. A careful oral hygiene and frequent follow-up are the main recommendations in OLP patients rehabilitated with implants. 相似文献43.
44.
45.
Ana Carolina Araruna Alves Paulo de Tarso Camillo de Carvalho Marcio Parente Murilo Xavier Lucio Frigo Flávio Aimbire Ernesto Cesar Pinto Leal Junior Regiane Albertini 《Lasers in medical science》2013,28(2):529-536
Rheumatoid arthritis (RA) is an autoimmune inflammatory disease of unknown etiology. Treatment of RA is very complex, and in the past years, some studies have investigated the use of low-level laser therapy (LLLT) in treatment of RA. However, it remains unknown if LLLT can modulate early and late stages of RA. With this perspective in mind, we evaluated histological aspects of LLLT effects in different RA progression stages in the knee. It was performed a collagen-induced RA model, and 20 male Wistar rats were divided into 4 experimental groups: a non-injured and non-treated control group, a RA non-treated group, a group treated with LLLT (780 nm, 22 mW, 0.10 W/cm2, spot area of 0.214 cm2, 7.7 J/cm2, 75 s, 1.65 J per point, continuous mode) from 12th hour after collagen-induced RA, and a group treated with LLLT from 7th day after RA induction with same LLLT parameters. LLLT treatments were performed once per day. All animals were sacrificed at the 14th day from RA induction and articular tissue was collected in order to perform histological analyses related to inflammatory process. We observed that LLLT both at early and late RA progression stages significantly improved mononuclear inflammatory cells, exudate protein, medullary hemorrhage, hyperemia, necrosis, distribution of fibrocartilage, and chondroblasts and osteoblasts compared to RA group (p?<?0.05). We can conclude that LLLT is able to modulate inflammatory response both in early as well as in late progression stages of RA. 相似文献
46.
47.
48.
Zoppoli G Bianchi F Bruzzone A Calvia A Oneto C Passalia C Balleari E Bedognetti D Ponomareva E Nazzari E Castelletti L Castellan L Minuto F Ghio R Ferone D 《Pituitary》2012,15(2):209-214
Polycythemia associated with acromegaly is usually caused by the systemic manifestations of the disease, such as sleep-apnea or concomitant erythropoietin-secreting kidney tumors. The recognition of underlying pathologies requires a thorough diagnostic process. We report a unique case of acromegaly with polycythemia, not caused by commonly described manifestations of the disease, and receding with octreotide therapy. The medical history of 141 acromegalic patients followed by the Endocrinology Unit of the San Martino University Hospital in Genoa has been also reviewed, together with the literature evidence for similar cases. The diagnostic workflow and 2-years follow-up of a 43-years old acromegalic, polycythemic man with a history of past smoking, moderate hypertension, and mental retardation are described. The hematological parameters of our cohort was retrospectively compared with those of a healthy, age/gender-related control group as well. Therapy with octreotide LAR, 20?mg i.m. q28d was begun soon after diagnosis of acromegaly in the polycythemic patient. Haematocrit level, hormonal setting, as well as pituitary tumor size and visual perimetry during treatment were recorded. Octreotide LAR treatment normalized hormonal alterations, as well as hematological parameters. Polycythemia has not recurred after 2?years of therapy. The median hemoglobin and hematocrit levels of the retrospectively analyzed cohort of acromegalic were significantly lower than normal ranges of a healthy, age/sex- related control population. In conclusions, polycythemia can be a direct, albeit rare, secondary manifestation of acromegaly, that must be considered during the diagnostic work-up of acromegalic patients presenting with such disorder. 相似文献
49.
Ana M. Ramos-Levi Andres Sanchez-Pernaute Lucio Cabrerizo Pilar Matia Ana Barabash Carmen Hernandez Alfonso L. Calle-Pascual Antonio J. Torres Miguel A. Rubio 《Obesity surgery》2013,23(12):2020-2025
Background
Remission of type 2 diabetes (T2D) is a desired outcome after bariatric surgery (BS). Even if this goal is not achieved, individuals who do not strictly fulfill remission criteria experience an overall improvement. The aim of this study was to evaluate the metabolic control status in patients considered as diabetes “non-remitters.”Methods
A retrospective study of 125 patients (59.2 % women) with preoperative diagnosis of T2D who underwent BS in a single center (2006–2011) was conducted. We collected anthropometric and metabolic parameters before surgery and at 1-year follow-up. T2D remission was defined according to the 2009 consensus statement: glycosylated hemoglobin (HbA1c) <6 %, fasting glucose (FG) <100 mg/dLs, and absence of pharmacologic treatment. We evaluated metabolic status of non-remitters, according to the American Diabetes Association's (ADA) target recommendations: HbA1c <7 %, LDL-c <100 mg/dL, triglycerides <150 mg/dL, and HDL-c >40 (male) or >50 mg/dL (female). Statistics: analysis of variance.Results
Baseline characteristics (mean ± SD): age 53.5?±?9.7 years, BMI 43.5?±?5.6 kg/m2, time since diagnosis of T2D 7.7?±?7.9 years, FG 162.0?±?56.3 mg/dL, HbA1c 7.7?±?1.6 %. ADA's target recommendations were present in 12 patients (9.6 %) preoperatively, and in 45 (36.0 %) at 1-year follow-up (p <0.001). Sixty-two (49.6 %) patients did not achieve diabetes remission; 26 (41.9 %) had now diet treatment, 30 (48.4 %) oral medications, and 6 (9.7 %) required insulin. Of the non-remitters, 57 (91.9 %) had HbA1c <7 % and 18 (40.0 %) achieved ADA's target recommendations. There were no differences between remitters and non-remitters in the number of individuals reaching ADA's combined metabolic control.Conclusions
Although almost 50 % of the patients may not be classified as diabetes remitters, their significant improvement in metabolic control should be regarded as a success, according to most scientific societies' target recommendations. 相似文献50.
Mari Eli Leonelli de Moraes Luiz Cesar de Moraes Mayra Cardoso Weber Ursi Sergio Lucio Pereira de Castro Lopes 《Research in developmental disabilities》2013,34(11):4274-4279
It is important to estimate both chronological age (CA) and maturational age of an individual, in order to perform orthopedic treatment or surgery, and in cases of lost documentation. Use of dental age (DA) for these purposes has been widely studied; however, the literature is scarce with regard to individuals with Down syndrome (DS), a prevalent condition worldwide. In this study the chronology of dental maturation was evaluated by analyzing the DA of individuals with DS based on the Chronological Mineralization Table proposed by Nolla (1960). Thus, second molars were evaluated in 57 panoramic radiographs of male and female individuals with DS, between 5 and 16 years-old. These data were compared with a control group of 191 nonsyndromic individuals of the same age group. Correlation between CA and DA was ascertained using Pearson's correlation coefficient (r), and the difference between these variables was measured using Student's t-test for paired samples and the method proposed by Bland and Altman. The difference between DA and CA was compared between the control and DS groups using Student's t-test for independent samples (α = 0.05). DA was slightly lower than the CA; however, this difference was only significant for females. The difference between DA and CA was not significant between individuals with DS and control group (both genders, p = 0.945; males, p = 0.542; females, p = 0.381). We concluded that dental maturation in individuals with DS occurs similarly to that of nonsyndromic individuals. 相似文献